Oxford Nanopore Technologies Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere.
The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis.
The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins.
The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments.
With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries!
We are looking for an experienced individual to join our Biologics Tech Transfer team as a Biologics Tech Transfer Scientist with the responsibility to onboard, develop and maintain new digital documentation processes.
The Details…
Reporting to the Principal Scientist, Biologics, the successful candidate will be responsible for onboarding digital documentation through a manufacturing execution system, to develop this platform and to maintain it once it is being widely used within the Tech Transfer, engineering and manufacturing teams. This role will involve translating both new and existing processes into a robust and intuitive digital document.
This role will also involve working on cross functional projects with team members from other departments to successfully deliver complex projects.
What We're Looking For…
We'll expect you to have relevant laboratory experience, ideally within a chemistry, biochemistry or pharmaceutical environment. You should have some basic coding knowledge and be familiar with GMP and GLP. Knowledge of continuous improvement methodologies would also be beneficial.
We're looking for an individual who is well organised, resilient under pressure with a good eye for detail and who likes to take a systematic approach to work. This role will suit someone who is quality and process driven, team orientated, responsive to customer needs and who wants to influence change positively and effectively. A BSc or equivalent relevant experience is required.
We offer outstanding benefits to include an attractive bonus, generous pension contributions, private healthcare and an excellent starting salary.
If you are looking to utilise your skills to really make a difference to humankind, then consider joining our team and apply today!
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-JC1
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
